Company not doing business... be careful ! All assets were sold to Inovo before B/K. Inovo closed on the sale of CHAD Therapeutics’ oxygen conserving assets in February of 2008, and completed the relocation of CHAD’s manufacturing, sales and marketing functions to its Naples headquarters in June of this year. Inovo retains the right to market and sell under the name of CHAD Therapeutics. http://www.chadtherapeutics.com/international/file/sales_support_files/CHAD%20Finds%20Home%20in%20Naples.pdf George Harris CEO Chad Therapeutics/Inovo, Inc. 2975 Horseshoe Drive South Suite 600 Naples, FL 34104 (239) 643-6577, ext. 220